UOC
UBS O'Connor’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Buy |
131,294
+24,206
| +23% | +$338K | 0.09% | 154 |
|
|
2025
Q1 | $1.44M | Buy |
107,088
+62,488
| +140% | +$842K | 0.04% | 140 |
|
|
2024
Q4 | $855K | Buy |
+44,600
| New | +$855K | 0.02% | 237 |
|
|
2024
Q3 | – | Sell |
-10,057
| Closed | -$131K | – | 540 |
|
|
2024
Q2 | $131K | Sell |
10,057
-6,400
| -39% | -$83.3K | ﹤0.01% | 394 |
|
|
2024
Q1 | $288K | Sell |
16,457
-13,543
| -45% | -$237K | 0.01% | 357 |
|
|
2023
Q4 | $653K | Sell |
30,000
-54,836
| -65% | -$1.19M | 0.02% | 313 |
|
|
2023
Q3 | $1.3M | Buy |
84,836
+10,000
| +13% | +$153K | 0.02% | 296 |
|
|
2023
Q2 | $1.78M | Buy |
74,836
+11,293
| +18% | +$269K | 0.04% | 318 |
|
|
2023
Q1 | $1.62M | Buy |
+63,543
| New | +$1.62M | 0.04% | 355 |
|
|
2022
Q4 | – | Sell |
-81,870
| Closed | -$1.68M | – | 318 |
|
|
2022
Q3 | $1.68M | Buy |
81,870
+47,481
| +138% | +$974K | 0.02% | 663 |
|
|
2022
Q2 | $398K | Buy |
+34,389
| New | +$398K | ﹤0.01% | 803 |
|